Renal stone disease in children

Clinical Pediatrics

Volumn 37, Issue 10, 1998, Pages 583-599

  Santos Victoriano, Myiene ^a   Brouhard, Ben H ^a   Cunningham III, Robert J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CALCIUM; CAPTOPRIL; CITRATE POTASSIUM; CYSTINE; MAGNESIUM HYDROXIDE; PENICILLAMINE; PHOSPHATE; PYRIDOXINE; STRUVITE; THIAZIDE DIURETIC AGENT; TIOPRONIN; URIC ACID;

ARTICLE; CHEMICAL COMPOSITION; CLINICAL FEATURE; CYSTINURIA; DIURETIC THERAPY; EXTRACORPOREAL LITHOTRIPSY; HUMAN; HYDRATION; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICOSURIA; NEPHROLITHIASIS; NEPHROLITHOTOMY; PROTEIN RESTRICTION; SODIUM RESTRICTION; STONE ANALYSIS; URINALYSIS;

EID: 0031784854     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289803701001     Document Type: Article

References (150)

1. Lemann J Jr. Composition of the diet and calcium kidney stones. N Engl J Med. 1993;328:880-881.
2. Sierakowski R, Finlayson B, Landes RR, et al. The frequency of urolithiasis in hospital discharge diagnosis in the United States. Invest Urol. 1978;15:483-491.
3. Noe HN, Stapleton FB, Jerkins OR, et al. Clinical experience with pediatric urolithiasis. J Urol. 1983;129:1166-1168.
4. Walther PC, Lamm D, Kaplan GW. Pediatric urolithiasis: a ten-year review. Pediatrics. 1980;65:1068-1072.
5. Sutor DJ, Wooley SE, Illingworth JJ. A geographical and historical survey of the composition of urinary stones. Br J Urol. 1974;46:393-407.
6. Scott R. Epidemiology of stone disease. Br J Urol. 1985;57:491-497.
7. Thalut K, Rizal A, Brockis JG, et al. The endemic bladder stones of Indonesia - epidemiology and clinical features. Br J Urol. 1976;48:617-621.
8. Choi H, Synder HM III, Duckett JW. Urolithiasis in childhood: current management. J Pediatr Surg. 1987;22: 158-164.
9. Bensman A, Roubach L, Allouch G, et al. Urolithiasis in children. Acta Paediatr Scand. 1983;72:879-883.
10. Gearhart JP, Herzberg GZ, Jeffs RD. Childhood urolithiasis: experiences and advances. Pediatrics. 1991;87:445-450.
11. Basaklar AC, Kale N. Experiences with childhood urolithiasis. Br J Urol 1991; 67:203-205.
12. Androulakakis PA, Michael V. Polychronopuolou S, et al. Paediatric urolithiasis in Greece. Br J Urol. 1991; 67:206-209.
13. Milliner DS, Murphy ME. Urolithiasis in pediatric patients. Mayo Clin Proc. 1993;68:241-248.
14. Nimmannit S, Malasit P, Susaengrat W, et al. Prevalence of endemic distal renal tubular acidosis and renal stones in the northeast of Thailand. Nephron. 1996;72:604-610.
15. Mari P, Bagga A, Vasudev V, et al. Aetiology of nephrolithiasis in north Indian children. Pediatr Nephrol 1995;9: 474-475.
16. Polinsky MS, Kaiser BA, Baluarte HJ, et al. Renal stones and hypercalciuria. Adv Pediatr. 1993;40:353-384.
17. Bennett AH, Colodny AH. Urinary tract calculi in children. J Urol. 1973; 109:318-320.
18. Stapleton FB. Nephrolithiasis in children. Pediatr Rev. 1989;11:21-30.
19. Barratt TM. Urolithiasis and nephrocalcinosis. In: Holliday MA, Barratt TM, Avner ED, eds. Pediatric Nephrology, 3rd ed. Baltimore: Williams and Wilkins; 1994:1070-1080.
20. Diamond DA, Rickwood AMK, Lee PH, et al. Infection stones in children: a twenty-seven-year review. Urology. 1994;43:52.
21. Shepherd P, Thomas R, Harmon EP. Urolithiasis in children: innovations in management. J Urol. 1988;140:790-792.
22. Polinsky MS, Kaiser BA, Baluarte HJ. Urolithiasis in childhood. Pediatr Clin North Am. 1987;34:683-710.
23. Fleisch H. Inhibitors and promoters of stone formation. Kidney Int. 1978; 13:361-371.
24. Smith L. Solutions and solute. Endocrinol Metab Clin North Am. 1990;19: 767-772.
25. Coe FL, Nakgawa V, Asplin J, et al. Role of nephrocalcinin in inhibition of calcium oxalatc crystallization and nephrolithiasis. Miner Electrolyte Metab. 1994;20:378-384.
26. Thompson B, Harwood-Nuss AL. Urolithiasis in a child: an uncommon presentation of an uncommon disease. Ann Emerg Med. 1995;25:837-840.
27. McSherry E. Renal tubular acidosis in childhood. Kidney hit. 1981;20:799-809.
28. Goldfarb S. The role of diet in the pathogenesis and therapy of nephrolithiasis. Endocrinol Metab Clin North Am. 1990;19:805-820.
29. Urivetsky M, Kessaur D, Smith AD. Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol 1992;147:1215-1218.
30. Herzberg GZ, Fivush BA, Kinsman SL, et al. Urolithiasis associated with ketogenic diet. J Pediatr. 1990;117:743-745.
31. Pahira JJ. Management of the patient with cystinuria. Urol Clin North Am. 1987;14:339-346.
32. Diament MJ, Malekzadeh M. Ultrasound and the diagnosis of renal and ureteral calculi. J Pediatr. 1986;109; 980-983.
33. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327:1141-1152.
34. Milliner DS. Cystinuria. Endocrinol Metab Clin North Am. 1990;19:889-907.
35. Byrd DJ, Lind M, Brodehl J. Diagnostic and genetic studies in 43 patients with classic cystinuria. Clin Chem. 1991;37:68-73.
36. Wasserstein AG, Stolley PD, Soper KA, et al. Case-control study of risk factors for idiopathic calcium nephrolithiasis. Miner Electrolyte Metab. 1987;13:85-95.
37. Kleeman CR, Bohannan J, Bernstein D, et al. Effect of variations in sodium intake on calcium excretion in normal humans. Proc Soc Exp Biol Med. 1964;115:29-32.
38. Kok DJ, Iestra JA, Doorenbos CJ. The effects of dietary excesses in animal protein and in sodium composition and the crystallization kinetics of calcium oxalate monohydrate in urine of healthy men. J Clin Endocrinol Metab. 1990;71:861-867.
39. Lemann Jr J, Gray RW, Maierhofer WJ, Cheung HS. The importance of renal net acid excretion as a determinant of fasting urinary calcium excretion. Kidney Int. 1986;29:743-746.
40. Brown WW, Wolfson M. Diet as culprit or therapy. Med Clin North Am. 1993; 77:783-794.
41. Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease. J Urol. 1996;155:432-440.
42. Bataille P, Charransol G, Gregoire I, et al. Effect of calcium restriction in renal excretion of oxalate and the probability of stones in the various pathophysiological group with calcium stones. J Urol. 1983;130:218.
43. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1995;98:50-59.
44. Baran DT. Hypercalciuria. Am J Dis Child. 1982;136:667-668.
45. Goldfarb S. Diet and nephrolithiasis. Annu Rev Med. 1994;45:235-243.
46. Hughes J, Norman RW. Diet and calcium stones. Can Med Assoc J. 1992; 146:137-143.
47. Curhan GC, Curhan SO. Dietary factors and kidney stone formation. Compr Ther. 1994;20:485-489.
48. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833-838.
49. Lemann JJ, Pleuss JA, Gray RW, et al. Potassium administration increases and potassium deprivation reduces urinary calcium excretion in healthy adults. Kidney Int. 1991;39:973-983.
50. Lemann JJ, Gray RW, Pleuss JA. Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men. Kidney Int. 1989; 35:688-695.
51. Cirillo M, Laurenzi M, Panarelli W, et al. Urinary sodium to potassium ratio and urinary stone disease. Kidney Int. 1994;46:1133-1139.
52. Osorio AV, Alon US. The relationship between urinary calcium, sodium and potassium excretion and the role of potassium in treating idiopathic hypercalciuria. Pediatrics. 1997;100:675-681.
53. Segura JW. Current surgical approaches to urolithiasis. Endocrinol Metab Clin North Am. 1990;19:919-935.
54. Thomas R, Ortenberg J, Lee BR, et al. Safety and efficacy of pediatric ureteroscopy for management of calculous disease. J Urol. 1993;149:1082-1084.
55. Riehle RA Jr, Fair WR, Vaughan ED Jr. Extracorporeal shock-wave lithotripsy for upper urinary tract calculi. JAMA. 1986;255:2043-2048.
56. Nijman RJM, Ackaert K, Scholtoneijer RJ, et al. Long-term results of extracorporeal shock wave lithotripsy in children. J Urol. 1989;142:609-611.
57. Longo JA, Netto NRJr. Extracorporeal shock-wave lithotripsy in children. Urology. 1995;46:550-552.
58. Bhatia V, Biyani CS. Extracorporeal shock wave lithotripsy in urolithiasis. Int Surg. 1994;79:80-83.
59. Kramolowsky EV, Willoughhy BL, Loening SA. Extracorporeal shock wave lithotripsy in children. J Urol. 1987;137:939-941.
60. Vandeursen H, Devos P, Bacrt L. Electromagnetic extracorporeal shock wave lithotripsy in children. J Urol. 1991;145:1229-1231.
61. Newman DM, Coury T, Lingeman JE, et al. Extracorporeal shock wave lithotripsy experience in children. J Urol. 1986;136:238-240.
62. Mininberg DT, Steckler R, Riehle RA Jr. Extracorporeal shock-wave lithotripsy for children. Am J Dis Child. 1988;142:279-282.
63. Harmon EP, Neal DE, Thomas R. Pediatric urolithiasis: a review of research and current management. Pediatr Nephrol 1994;8:508-512.
64. Krysiewicz S. Complications of renal extracorporeal shock wave lithotripsy reviewed. Urol Radiol 1992;13:139-145.
65. Kroovand RL, Harrison LH, McCullough DL. Extracorporeal shock wave lithotripsy in childhood. J Urol. 1987; 138:1106-1108.
66. Sigman M, Laudone VP, Jenkins AD, et al. Initial experience with extracorporeal shock wave lithotripsy in children. J Urol. 1987;138:839-841.
67. Frick J, Kohle R, Kunit G. Experience with extracorporeal shock wave lithotripsy in children. Eur Urol. 1988;14:181-183.
68. Aladjem M, Barr J, Lahat E, et al. Renal and absorptive hypercalciuria: a metabolic disturbance with varying interchanging modes of expression. Pediatrics. 1996;97:216-219.
69. Stapleton FB, the Southwestern Pediatric Nephrology Study Group. Idiopathic hypercalciuria: association with isolated hematuria and risk for urolithiasis in children. Kidney Int. 1990;37:807-811.
70. Stapleton FB, Noe HN, Roy S III, et al. Hypercalciuria in children with urolithiasis. Am J Dis Child. 1982;136: 675-678.
71. Harangi F, Mehen K. Family investigations in idiopathic hypercalciuria. Eur J Pediatr. 1993;152:64-68.
72. Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med. 1979;300:337-340.
73. Stapleton FB. Hematuria associated with hypercalciuria and hyperuricosuria: a practical approach. Pediatr Nephrol 1994;8:756-761.
74. Kalia A, Travis LB, Brouhard B. The association of idiopathic hypercalciuria and asymptomatic gross hematuria in children. J Pediatr. 1981;99: 716-719.
75. Alon US, Warady BA, Hellerstein S. Hypercalciuria in the frequency-dysuria syndrome of childhood. J Pediatr. 1990;116:103-105.
76. Vachvanichsanong P, Malagon M, Moore E. Urinary incontinence due to idiopathic hypercalciuria in children. J Urol. 1994;152:1226-1228.
77. Sutton RAL. Diuretics and calcium metabolism. Am J Kidney Dis. 1985;5:4-9.
78. Coe FL, Parks JH, Bushinsky DA, et al. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 1988;33:1140-1146.
79. Fuss M, Peppersack T, Bergman P, et al. Low calcium diet in idiopathic urolithiasis: a risk factor for osteopenia as great as in primary hyperparathyroidism. Br J Urol. 1990;65: 560-563.
80. 3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med. 1982;72:25-32.
81. Lawoyin S, Sismilich S, Brown R, Pak CYC. Bone mineral content in patients with calcium urolithiasis. Metabolism. 1979;28:1250-1254.
82. Malluche HH, Tschoepe W, Ritz E, et al. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab. 1980;50:654-658.
83. Barkin J, Wilson DR, Manuel MA, et al. Bone mineral content in idopathic calcium nephrolithiasis. Miner Electrolyte Metab. 1985;11:19-24.
84. Galosy R, Clarke L, Ward DL, Pak CYC. Renal oxalate excretion in calcium urolithiasis. J. Urol. 1980;123: 320-323.
85. Reusz GS, Dobos M, Byrd D. Urinary calcium and oxalate excretion in children. Pediatr Nephrol. 1995;9:39-44.
86. Karlowicz MG, Katz ME, Adelman RD, et al. Nephrocalcinosis in very low birth weight neonates: family history of kidney stones and ethnicity as independent risk factors. J Pediatr. 1993;122:635-638.
87. Katz ME, Karlowicz MG, Adelman RD, et al. Nephrocalcinosis in very low birth weight neonates: sonographic patterns, histological characteristics, and clinical risk factors. J Ultrasound Med. 1994;13:777-782.
88. Alon US, Scagliotti D, Garola R. Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. J Pediatr. 1994;125:149-151.
89. Thomas WC Jr. Urinary calculi in hypercalcemic states. Endocrinol Metab Clin North Am. 1990;19:839-849.
90. Buckalew VM Jr. Nephrolithiasis in renal tubular acidosis. J Urol 1989;141: 731-737.
91. Caruana RJ, Buckalew VM Jr. The syndrome of distal (type I) renal tubular acidosis. Medicine. 1988;67:84-99.
92. Pak CYC. Citrate and renal calculi: an update. Miner Electrolyte Metab. 1994; 20:371-377.
93. Parks JH, Coe FL. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986;30: 85-90.
94. Ackay T, Konukkoglu D, Celik C. Hypocitraturia in patients with urolithiasis. Arch Dis Child. 1996;74: 350-351.
95. Norman ME, Feldman NI, Cohn RM, et al. Urinary citrate excretion in the diagnosis of distal renal tubular acidosis. J Pediatr. 1978;92:394-400.
96. Pak CYC, Koenig K, Khan R, et al. Physicochemical action of potassium magnesium citrate in nephrolithiasis. J Bone Miner Res. 1992;7:283-287.
97. Hibbard EW, Wendzilak TR. Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol. 1989;141: 742-747.
98. Earnest DL, Johnson G, Williams HE, et al. Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption. Gastroenterology. 1974;66:1114.
99. Binder HJ. Intestinal oxalate absorption. Gastroenterology. 1974;67:441-446.
100. Kalhpalia SC, Favus MJ, Coe FL. Evidence for size and charge permselectivity of rat ascending colon. J Clin Invest. 1984;74:805-881.
101. Watts RWE. Primary hyperoxaluria type I. QJ Med. 1994;87:593-600.
102. Barratt TM, Danpure CJ. Hyperoxaluria. In: Holliday MA, Barratt TM, Avner ED, eds. Pediatric Nephrology, 3rd ed. Baltimore: Williams and Wilkins; 1994:557-572.
103. Scheinman JI. Primary hyperoxaluria. Miner Electrolyte Metab. 1994;20:340-351.
104. Cochat P, Deloraine A, Olive F, et al. Primary hyperoxaluria type I: the therapeutic dilemma. Adv Nephrol. 1995;24:227-242.
105. Danpure CJ, Jennings PR, Watts RWE. Enzymological diagnosis of primary hyperoxaluria type I by measurement of hepatic alanine:glyoxylate aminotransferase activity. Lancet. 1987;1:289-291.
106. Morgan SH, Danpure CJ, Bending MR, Eisinger AJ. Exclusion of primary hyperoxaluria type I (PH I) in end stage renal failure by enzymatic analysis of a percutaneous hepatic biopsy. Nephron. 1990;55:336-337.
107. Milliner DS, Eickholt JT, Bergstrahl EJ. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med. 1994;331:1553-1558.
108. Yendt ER, Cohanim M. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria. N Engl J Med. 1985;312:953-957.
109. Dretler SP. Chemolysis of urinary calculi. AUA Update Series 1986; vol 5, lesson 21.
110. Singer A, Das S. Cystinuria: a review of the pathophysiology and management. J Urol. 1989;142:669-673.
111. Noronha RFX, Gregory JG, Duke JJ. Urolithiasis in children. J Urol. 1979; 121:478-479.
112. Sinno K, Boyce WH, Resnick MI. Childhood urolithiasis. J Urol. 1979; 121:662-664.
113. Daeschner CW, Singleton EB, Curtis JC. Urinary tract calculi and nephrocalcinosis in infants and children. J Pediatr. 1960;57:721-732.
114. Sakhaee K, Poindexter JR, Pak CYG. The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis. J Urol. 1989;141:819-821.
115. Dahlberg PJ, Van Den Berg CJ, Kurtz SB, et al. Clinical features and management of cystinuria. Mayo Clin Proc. 1977;52:533-542.
116. Sakhaee K. Cystinuria: pathogenesis and treatment. Miner Electrolyte Metab. 1994;20:414-423.
117. Rodriguez LM, Santos F, Malaga S, Martinez V. Effect of a low sodium diet on urinary elimination of cystine in cystinuric children. Nephron. 1995; 71:416-418.
118. Streem SB, Hall P. Effect of captopril on urinary cystine excretion in homozygous cystinuria. J Urol. 1989;142: 1522-1524.
119. Sloand JA, Izzo JL Jr. Captopril reduces urinary cystine excretion in cystinuria. Arch Intern Med. 1987;147: 1409-1412.
120. Perazella MA, Buller GK. Successful treatment of cystinuria with captopril. Am J Kidney Dis. 1993;21:504-507.
121. Cohen T, Streem SB, Hall P. Clinical effect of captopril on the formation and growth of cystine calculi. J Urol. 1995;154:164-166.
122. Coulthard MG, Richardson J, Fleetwood A. The treatment of cystinuria with captopril (letter). Am J Kidney Dis. 1995;25:661-662.
123. Dahlberg PJ, Jones JD. Cystinuria: failure of captopril to reduce cystine excretion (letter). Arch Intern Med. 1989;149:713-712.
124. Michelakakis H, Delis D, Anastasiadou V, et al. Ineffectiveness of captopril in reducing cystine excretion in cystinuric children. J Inherit Metab Dis. 1993;16:1042-1043.
125. Aunsholt NA, Ahlborn G. Lack of effect of captopril in cystinuria (letter). Clin Nephrol 1990;34:92-93.
126. Chow GK, Streem SB. Medical treatment of cystinuria: results of contemporary clinical practice. J Urol. 1996; 156:1576-1578.
127. Cameron JS, Moro F, Simmonds HA. Gout, uric acid, and purine metabolism in pediatric nephrolithiasis. Pediatr Nephrol. 1993;7:105-118.
128. Stapleton FB, Linshaw MA, Hassanein K, Gruskin AB. Uric acid excretion in normal children. J Pediatr. 1978;92:911-914.
129. Halabe A, Sperling O. Uric acid nephrolithiasis. Miner Electrolyte Metab. 1994;20:424-431.
130. Lerner SP, Gleeson MJ, Griffith DP. Infection slones. J Urol. 1989;141:753-759.
131. Griffith DP. Struvite stones. Kidney Int. 1978;13:371-382.
132. Thompson RB, Stamey TA. Bacteriology of infected stones. Urology. 1973; 2:627-633.
133. Muldoon LD, Resnick MI. Secondary urolithiasis. Endocrinol Metab Clin North Am. 1990;19:909-918.
134. Griffith DP. Infection-induced renal calculi. Kidney Int. 1982;21:422-430.
135. Dretler SP. The pathogenesis of urinary tract calculi occurring after ileal conduit diversion. J. Urol. 1977;117: 577.
136. Wenzl JE, Burke EC, Stickler GB, et al. Nephrolithiasis and nephrocalcinosis in children. Pediatrics. 1968;41:57-61.
137. Meadow R. Munchausen syndrome by proxy. Arch Dis Child. 1982;57:92-98.
138. Sneed RG, Bell RF. The dauphin of Munchausen: factitious passage of renal slones in a child. Pediatrics. 1976; 58:127-130.
139. Sharon E, Diamond HS. Factitious uric acid urolithiasis as a feature of the Munchausen syndrome. Mt. Sinai J Med. 1974;41:696-698.
140. Atkinson RL Jr, Earil JM. Munchausen syndrome with renal stones. JAMA. 1974;230:89.
141. Karlen J, Aperia A, Zetterrstrom R. Renal excretion of calcium and phosphate in preterm and term infants. J. Pediatr. 1985;106:814-819.
142. Stapleton FB, Nash DA. A screening test for hyperuricosuria. J Pediatr. 1983;102:88-90.
143. Hoppe B, Langman CB. Hypocitraturia in patients with urolithiasis. Arch Dis Child. 1997;76:174-175.
144. Wandzilak TR, Williams HE. The hyperoxaluric syndromes. Endocrinol Metab Clin North Am. 1990;19:851-867.
145. Koehl C, Abecassis J. Determination of oxalic acid in urine by atomic absorption spectrophotometry. Clin Chim Acta. 1976;70:71-77.
146. Olthius FMFG, Markslang AMG, Klein JT, et al. Urinary oxalate estimation. Clin Chim Acta. 1991;75:123-128.
147. Wilson DM, Liedthe RR. Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: reference values and sample handling procedures. Clin Chem. 1991;37:1229-1235.
148. Pak CYC. Cystine lithiasis. In: Resnick MI, Pak CY, eds. Urolithiasis - A Medical and Surgical Reference. Philadelphia: WB Saunders; 1990:133.
149. Morganstern BZ, Milliner DS, Murphy ME, et al. Urinary oxalate and glycolate excretion patterns in the first year of life: a longitudinal study. J Pediatr. 1993;123:248-251.
150. Barratt TM, Kasidas GP, Murdoch I, Rose GA. Urinary oxalate and glycolate excretion and plasma oxalate concentration. Arch Dis Child. 1991; 66:505-503.